Anika Therapeutics, Inc. — Director's Dealing 2021

Jul 12, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anika Therapeutics, Inc. (ANIK)
CIK: 0000898437
Period of Report: 2021-07-08

Reporting Person: Loerop James (EVP Business Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-08	Common Stock	M	3000	—	Acquired	6323	Direct
2021-07-08	Common Stock	F	731	$43.24	Disposed	5592	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-08	Restricted Stock Unit	$0.00	M	3000	Acquired		Common Stock (3000)	Direct

Footnotes

F1: Reflects the second vesting installment of RSUs granted on July 8, 2019.

F2: Reflects an aggregate of 731 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on July 8, 2021.

F3: Reflects the closing price of ANIK common stock on July 8, 2021, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.